Diplon, Jeffrey .

HRN: 10-41-01  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2023
MUPIROCIN 2%, 15G (TUBE)
10/15/2023
10/22/2023
TOPICAL
2%
TID
Abrasion
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes